Speaker Biography

Ian James Martins

Ian James Martins, Edith Cowan University, Australia

Title: Diagnosis and Management of Immunological Diseases requires Sirtuin 1 as a Diagnostic protein marker

Ian James Martins

Dr. Ian Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Appointed as the Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). He is now a Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The total citations over the past 27 years of scientific research has accumulated to approx. 3300. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places publication Stats RG score higher than 96% of the international SCIENTISTS. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates of appreciation from various international conferences have been received in relation to anti-aging, health and disease. Keynote addresses at Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016.



Laboratory evaluations using established and emerging techniques in immunology are essential for the diagnosis and management of immune-mediated disorders. Inter-relationship between immunology and other laboratories such as chemistry, microbiology, and hematology now may overlap in diagnostic tests. Diagnosis of allergy, autoimmune disease serology, protein immunology including complement testing, cancer immunology, histocompatibility and immunogenetics, primary/secondary immunodeficiencies and infectious disease serology may now require analysis of a diagnositc protein that is critical for interpretation of global health and chronic disease. Sirtuin 1 analysis on blood, plasma and sera may be important to immunological tests with collection of plasma/sera sensitive to the appropriate preservative, freeze/thaw conditions and long term storage conditions. Bacterial lipopolysaccharides need to assayed on samples to avoid misinterpretations with relevance to Sirtuin 1 repression in immunological diseases.